Loading…
WTI settled $3.15 higher at $40.29 a barrel and Brent gained about $2.95 on November 9 after Pfizer and BioNTech reported a phase 3 vaccine efficacy above 90%. Prices pulled back during the session as New York COVID-19 cases rose sharply.
Rising case counts limited the rally, so the price gain depends on whether near-term demand losses from lockdowns outweigh the longer-term vaccine outlook. This keeps crude and diesel prices supported but volatile.
spglobal.comChris van MoessnerNov 9, 2020After 487 past bullish macro events, Crude Oil (WTI) moved a median +1.0% over 5 sessions (60% higher; middle half -2.0% to +4.0%), and +1.5% over 20.
After 323 past bullish macro events, Crude Oil (Brent) moved a median +0.7% over 5 sessions (58% higher; middle half -2.9% to +3.7%), and +1.3% over 20.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
Brent gained about $2.95 on the vaccine efficacy news, though prices pulled back intraday on rising COVID cases.
